Gamma Medica gets Saudi approval for LumaGem

Molecular imaging developer Gamma Medica announced the Saudi Food and Drug Authority (SFDA) issued a Medical Device Marketing Authorization (MDMA) for its LumaGem breast imaging system.

The MDMA allows Gamma Medica to market LumaGem using molecular breast imaging technology in Saudi Arabia. Integrated Business Ventures of Riyadh is Gamma Medica's authorized representative and strategic partner for the Saudi Arabia and the Middle East markets.

Page 1 of 435
Next Page